Mirdamadi Ahmad, Gharavi Hosna, Behjati Mohaddeseh
Department of Cardiology, Islamic Azad University, Najafabad Branch, Isfahan, Iran.
Gynecology Department, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Tanaffos. 2016;15(3):187-190.
Pregnancy is strongly discouraged in patients with pulmonary arterial hypertension (PAH). Herein, we report a successful delivery in a woman with PAH using a multidisciplinary approach. A 30-year-old pregnant woman with PAH was referred to us with a chief complaint of dyspnea. She was advised to terminate her pregnancy but she refused to do so despite several recommendations by healthcare professionals. She was scheduled for treatment with iloprost (brand name: Ilomedin) and heparin infusions for 3-4 days at 20-day intervals. She spent her last month of pregnancy in a hospital under close observation and received iloprost infusion. She underwent a successful cesarean section under general anesthesia at week 36 of gestation. Iloprost administration was continued for one week after delivery and was changed to bosentan after that. Meanwhile, heparin infusion was substituted by warfarin. However, treatment with bosentan led to a temporary interruption in breastfeeding. A few days later, she presented with severe dyspnea and pulmonary artery pressure of 110 mmHg. Treatment was restarted with iloprost, followed by stabilization with bosentan. A successful delivery was achieved in this situation by meticulous observation and aggressive treatment targeting PAH, along with long-term hospital stay and multidisciplinary management. Severe PAH is regarded as a contraindication to pregnancy. While physicians strongly recommend termination of pregnancy in such patients, some of them might refuse and insist on delivery of the baby. Similar pregnant cases with potential delivery are recommended to be evaluated for effective management of this condition.
肺动脉高压(PAH)患者强烈不建议怀孕。在此,我们报告一例采用多学科方法成功分娩的PAH女性病例。一名30岁的PAH孕妇因呼吸困难为主诉转诊至我院。她被建议终止妊娠,但尽管医疗专业人员多次建议,她仍拒绝这样做。她计划接受伊洛前列素(商品名:万他维)和肝素输注治疗,每20天进行3 - 4天。她在医院密切观察下度过了怀孕的最后一个月,并接受了伊洛前列素输注。她在妊娠36周时在全身麻醉下成功进行了剖宫产。产后伊洛前列素持续给药一周,之后改为波生坦。同时,肝素输注被华法林替代。然而,波生坦治疗导致母乳喂养暂时中断。几天后,她出现严重呼吸困难,肺动脉压达110 mmHg。治疗重新开始使用伊洛前列素,随后用波生坦稳定病情。通过针对PAH的细致观察、积极治疗、长期住院以及多学科管理,在此情况下实现了成功分娩。严重PAH被视为怀孕的禁忌症。虽然医生强烈建议此类患者终止妊娠,但其中一些人可能会拒绝并坚持分娩。对于类似可能分娩的怀孕病例,建议进行评估以有效管理这种情况。